View Post

Guillain-Barré Syndrome Risk Identified in Norovirus Vaccine Candidate

In COVID-19, Latest News by Precision Vaccinations

With cruise ship voyages reporting additional norovirus outbreaks in 2025, vaccines that protect people against human norovirus disease are in demand.
Historically, developing a broadly effective norovirus vaccine has been challenging owing to the genetic and antigenic diversity of noroviruses.
Another concern has arisen due to Moderna Inc.'s recent announcement.

View Post

Infected Mosquitoes May Disrupt Brazil's Carnival 2025

In COVID-19, Latest News by Precision Vaccinations

While Carnival 2025 is a global celebration, the Federative Republic of Brazil's events in Sao Paulo and Rio de Janeiro may be most visited by international travelers from late February to early March.
Millions of Carnival participants, including about 200,000 visitors, will enjoy warm beaches, parades, and cultural festivities.
However, as of February 16, 2025, Carnival attendees in São Paulo State may be at risk for mosquito-transmitted diseases such as chikungunya, dengue, and yellow fever.

View Post

Mosquitoes Can Carry Three Alphaviruses Simultaneously

In COVID-19, Latest News by Precision Vaccinations

There is increasing evidence people have been co-infected with various combinations of mosquito-transmitted diseases. When this occurs, diagnosing which disease is causing impacting a person becomes challenging. 
For example, during 2024 and early 2025, outbreaks of chikungunya, dengue, and Zika viruses were reported in multiple countries in the Region of the Americas, such as Brazil.

View Post

100% Marburg Case Fatality Rate in Tanzania

In COVID-19, Latest News by Precision Vaccinations

The latest outbreak of Marburg virus disease (MVD) in Africa continues to cause a significant case fatality rate. Since the initial Marburg outbreak in Germany in 1967, there have been eighteen outbreaks of MVD that have previously been reported globally.
Since the declaration of the MVD outbreak on January 20, 2025, the United Republic of Tanzania's Ministry of Health has confirmed all ten 10 patients in the Kagera Region's Biharamulo and Muleba districts have died as of February 14, 2025.

View Post

Will Dengue Passive Immunization Become Available in the USA

In COVID-19, Latest News by Precision Vaccinations

As travelers in the United States prepare for another year of record-setting Dengue fever outbreaks, a human monoclonal antibody (mAb) candidate from a Bethesda, MD-based company may soon obtain U.S. FDA approval.
As of February 12, 2025, the National Institutes of Health and AbViro LLC phase IIa clinical trial is exposing healthy volunteers in Maryland and Vermont to a weakened strain of the Dengue virus. The study will compare three AV-1 dose levels in adults challenged with DENV-3, the most infectious Dengue virus strain.

View Post

Traveling Abroad During Ramadan is Rewarding

In COVID-19, Latest News by Precision Vaccinations

The British Islamic Medical Association (BIMA) says Ramadan is a holy month for Muslims, with many 'Brits' traveling abroad to visit friends and family.
This year, the MBIMA says the holy month is expected to begin on February 28, 2025, as the official start of Ramadan follows the lunar calendar, so it depends on the sighting of the moon.
In 2024, 30 million pilgrims performed Umrah during Ramadan, the Islamic pilgrimage in Saudi Arabia. Approximately 13.5 million pilgrims were international travelers, including United Kingdom residents.

View Post

HPV9 Vaccines Coming to Latin America

In COVID-19, Latest News by Precision Vaccinations

Over the past decade, human papillomavirus (HPV) vaccinations have prevented thousands of cervical cancer cases worldwide.
Beginning in July 2025, the enhanced 9-valent HPV vaccine will become more available in the Region of the Americas.
The Pan American Health Organization (PAHO) Revolving Fund announced on February 7, 2025, that the general availability of the 9-valent HPV vaccine will be easier and more affordable for Latin American countries.